DILLY STEPHEN GEORGE

CIK 00013891475 companiesALAMEDA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001389147

Recent Transactions

50 trades

Award
CODEXIS, INC.$CDXS
Common Stock
2025-11-11$1.85/sh+50,000→ 727,053 total
Award
CODEXIS, INC.$CDXS
Common Stock
2025-02-05+88,750→ 673,053 total
Award
CODEXIS, INC.$CDXS
Stock Option (Right to Buy)
2025-02-05+532,500→ 532,500 total
Award
CODEXIS, INC.$CDXS
Stock Option (Right to Buy)
2024-01-01+860,500→ 860,500 total
Award
CODEXIS, INC.$CDXS
Common Stock
2024-01-01+143,425→ 582,303 total
Purchase
CODEXIS, INC.$CDXS
Common Stock
2023-09-08$1.73/sh+58,479→ 438,878 total
Sale
CODEXIS, INC.$CDXS
Common Stock
2023-03-08$4.56/sh−26,987→ 380,399 total
Sale
CODEXIS, INC.$CDXS
Common Stock
2023-03-07$4.60/sh−28,088→ 407,386 total
Award
CODEXIS, INC.$CDXS
Common Stock
2023-02-21+112,500→ 146,474 total
Award
CODEXIS, INC.$CDXS
Stock Option (Right to Buy)
2023-02-21+337,500→ 337,500 total
Award
CODEXIS, INC.$CDXS
Common Stock
2023-02-08+289,000→ 435,474 total
Award
CODEXIS, INC.$CDXS
Stock Option (Right to Buy)
2022-08-01+700,000→ 700,000 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−165,000→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−92,000→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Common Stock
2022-07-01$55.00/sh−5,000→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−260,000→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−520,000→ 0 total
Award
Sierra Oncology, Inc.
Stock Option (Right to Buy)
2022-06-17+65,000→ 65,000 total
Award
CODEXIS, INC.$CDXS
Common Stock
2022-06-14+11,273→ 33,974 total
Award
Sierra Oncology, Inc.
Stock Option (Right to Buy)
2022-03-14+165,000→ 165,000 total
Award
Sierra Oncology, Inc.
Stock Option (Right to Buy)
2022-01-28+65,000→ 65,000 total
Award
CODEXIS, INC.$CDXS
Common Stock
2021-06-15+4,796→ 22,701 total
Purchase
Sierra Oncology, Inc.
Common Stock
2021-05-19$17.83/sh+5,000→ 5,000 total
Award
Sierra Oncology, Inc.
Stock Option (Right to Buy)
2021-03-15+92,000→ 92,000 total
Award
CODEXIS, INC.$CDXS
Common Stock
2020-06-16+17,905→ 17,905 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2020-06-01+520,000→ 520,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2020-05-18+10,000→ 15,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2020-05-18+15,000→ 15,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2020-05-18+20,000→ 20,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2020-05-18+2,500→ 7,500 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right-to-Buy)
2020-03-19−35,000→ 0 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2020-03-19$5.42/sh+35,000→ 40,000 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2020-03-19$6.00/sh−35,000→ 5,000 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right-to-Buy)
2020-03-16−15,000→ 35,000 total
Sale
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2020-03-16$6.02/sh−15,000→ 5,000 total
Exercise/Conversion
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2020-03-16$5.42/sh+15,000→ 20,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2019-06-10+2,500→ 5,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2019-06-10+15,000→ 15,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Common Stock
2018-06-11+2,500→ 2,500 total
Award
SANGAMO THERAPEUTICS, INC$SGMO
Stock Option (Right to Buy)
2018-06-11+15,000→ 15,000 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-06-11$3.02/sh+29,457→ 344,765 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-06-11$30.83/sh−29,457→ 315,308 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-06-11−29,457→ 295,942 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-06-08$30.70/sh−42,106→ 315,308 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-06-08−42,106→ 325,399 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-06-08$3.02/sh+42,106→ 357,414 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-06-07$31.58/sh−500→ 315,308 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-06-07$3.02/sh+32,598→ 347,906 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-06-07−32,598→ 367,505 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-06-07$30.95/sh−32,098→ 315,808 total

Companies

Recent Filings

Address

C/O AVIGEN, INC. 1301 HARBOR BAY PKWY

ALAMEDA, CA, 94502

View on SEC.gov